Shanghai Xuerong Biotechnology Co.,Ltd. (SHE:300511)
China flag China · Delayed Price · Currency is CNY
8.04
+0.01 (0.12%)
May 6, 2026, 4:00 PM EDT

SHE:300511 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
297.51161.45167.95252.67363.82340.77
Short-Term Investments
---0.06--
Trading Asset Securities
----270-
Cash & Short-Term Investments
297.51161.45167.95252.72633.82340.77
Cash Growth
564.38%-3.87%-33.54%-60.13%86.00%-55.16%
Accounts Receivable
46.0843.7731.3933.4829.0228.86
Other Receivables
5.788.65.556.2850.1318.89
Receivables
51.8752.3736.9539.7679.1547.74
Inventory
399.99371.68325.34442.86443.28384.08
Prepaid Expenses
--2.95.743.972.11
Other Current Assets
24.8920.5413.1725.5132.34100.24
Total Current Assets
774.26606.04546.31766.61,193874.94
Property, Plant & Equipment
2,5992,6642,9653,4602,5792,945
Long-Term Investments
-12.0515.616.2421.4632.61
Other Intangible Assets
296.19299.43299.63306.9221.72328.38
Long-Term Deferred Tax Assets
-----12.83
Long-Term Deferred Charges
5.646.147.9121.8126.4847.77
Other Long-Term Assets
33.2514.0919.8730.6830.8295.96
Total Assets
3,7093,6013,8554,6024,0724,337
Accounts Payable
259.58320.95298.35318.15215.87214.13
Accrued Expenses
49.6149.1278.0766.9261.8455.59
Short-Term Debt
366.9856.09967.851,036575.76777.49
Current Portion of Long-Term Debt
--146.19168.69170.4248.23
Current Portion of Leases
--1.054.011.131.07
Current Income Taxes Payable
-4.66---0.01
Current Unearned Revenue
10.826.4720.627.1616.2314.15
Other Current Liabilities
490.15519.51436.11512.47256.29295.98
Total Current Liabilities
1,1771,7571,9482,1131,2981,607
Long-Term Debt
739.7219.98960.21948.27973.69954.69
Long-Term Leases
16.6521.0721.4524.4123.4523.45
Long-Term Unearned Revenue
56.457.1960.5651.1243.8949.68
Other Long-Term Liabilities
30.8932.8440.7833.08107.6451.12
Total Liabilities
2,0212,0883,0313,1702,4462,686
Common Stock
640.85640.85498.82498.78503.04441.92
Additional Paid-In Capital
1,3141,314741.98741.82753.99471.77
Retained Earnings
-165.01-338.18-367.98249.09437.16724.38
Treasury Stock
-----16.43-34.7
Comprehensive Income & Other
-6-4.765.8164.8365.5165.98
Total Common Equity
1,7841,612938.631,5551,7431,669
Minority Interest
-95.91-98.53-115.31-122.15-117.43-17.5
Shareholders' Equity
1,6881,513823.321,4321,6261,652
Total Liabilities & Equity
3,7093,6013,8554,6024,0724,337
Total Debt
1,1231,0972,0972,1811,7442,005
Net Cash (Debt)
-825.73-935.69-1,929-1,928-1,111-1,664
Net Cash Per Share
-1.44-1.57-3.88-3.90-2.28-3.85
Filing Date Shares Outstanding
641.37683.11498.82498.78503.04507.6
Total Common Shares Outstanding
641.37683.11498.82498.78503.04441.92
Working Capital
-402.8-1,151-1,402-1,346-104.97-731.7
Book Value Per Share
2.782.361.883.123.473.78
Tangible Book Value
1,4881,313638.991,2481,5221,341
Tangible Book Value Per Share
2.321.921.282.503.023.03
Buildings
--2,3162,2831,9291,922
Machinery
--2,6872,5982,1872,209
Construction In Progress
--53.49360.3168.28151.74
Source: S&P Global Market Intelligence. Standard template. Financial Sources.